Mitochondrial Electron Transport Chain Complexes I, II, and III (CI, CII, CIII)

Mitochondrial electron transport chain complexes I (NADH:ubiquinone oxidoreductase), II (succinate dehydrogenase), and III (cytochrome bc1 complex) are large multi-subunit membrane-embedded enzymes that catalyze sequential electron transfer from NADH and FADH2 to ubiquinone and onwards to cytochrome c, coupling this flow to the translocation of protons across the mitochondrial inner membrane. This generates an electrochemical gradient exploited by ATP synthase to produce ATP. Their function is central to cellular energy metabolism, and their dysfunction or pharmacological inhibition broadly affects cell viability, signaling, and redox homeostasis, with strong implications in diverse diseases. Complex I, III, and IV are proton pumps; complex II is not. Complex II is unique as it participates directly in the citric acid cycle and the ETC. Major sites of drug action and ROS generation are complexes I and III, with complex II producing ROS primarily upon mutation. Recent structural studies have revealed assembly into supercomplexes (“respirasome”), optimizing electron flow and minimizing protein aggregation. These complexes are among the most studied bioenergetic enzymes and represent highly validated molecular targets for both mechanistic research and disease intervention.

Other names

NADH:ubiquinone oxidoreductaseNADH dehydrogenaseCISuccinate dehydrogenasesuccinate-coenzyme Q reductaseCIICytochrome bc1 complexubiquinol:cytochrome c oxidoreductaseCIII

Inhibition of electron transfer, collapsing the proton gradient and mitochondrial membrane potential (leading to ATP deficiency, increased ROS, and cell death); Modulation of ROS production (antioxidants, uncouplers); Rescue of defective complexes via bypass drugs (e.g., alternative oxidases—experimental).